Stock Price Quote

ALBERT DAVID LTD.

NSE : ALBERTDAVDBSE : 524075ISIN CODE : INE155C01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1191.6016.6 (+1.41 %)
PREV CLOSE ( ) 1175.00
OPEN PRICE ( ) 1180.95
BID PRICE (QTY) 1187.10 (8)
OFFER PRICE (QTY) 1191.60 (10)
VOLUME 1042
TODAY'S LOW / HIGH ( )1160.90 1199.00
52 WK LOW / HIGH ( )555 1605
NSE1190.9019 (+1.62 %)
PREV CLOSE( ) 1171.90
OPEN PRICE ( ) 1162.25
BID PRICE (QTY) 1187.70 (2)
OFFER PRICE (QTY) 1189.90 (4)
VOLUME 6090
TODAY'S LOW / HIGH( ) 1158.15 1201.40
52 WK LOW / HIGH ( )554.5 1607.9
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1938
Management Info
Arun Kumar Kothari - Chairman Umesh Manohar Kunte - Managing Director
Registered Office

Address D Block, 3rd Floor,Gillander House 8,Netaji Subhas Road,
Kolkata,
West Bengal-700001

Phone 033 22628436 / 8456 / 8492

Email albertdavid@adlindia.in

Website www.albertdavidindia.com

Registrars Details
Maheshwari Datamatics Pvt Ltd
23 RN Mukherjee Road, ,5th Floor (Old Address: 6 Mangaoe Lane 2nd Floor),,kokata
Listing : BSE, NSE

NEWS

23Apr Albert David informs about notice to s
In terms of Regulation 30 of the Securities and Exchange Board of India..
01Apr Albert David informs about retirement
In terms of Regulation 30 & Schedule III of the SEBI (Listing Obliga..
30Mar Albert David informs about issuance of
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
15Mar Albert David informs about details of
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..
14Mar Appointment of Company Secretary and
Intimation in terms of Regulation 30 of the Listing Regulations enclosed.

Financials

in Millions
QTR Dec 23 ANNUAL 23
Net Profit187.18361.75
Gross Profit 234.36 507.36
Operating Profit 252.37597.4
Net Sales 882.813415.64

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  3997.35 (4.08%)
M.Cap ( in Cr)105523.76
Astrazeneca Pharma I (BSE)
peergroup  5440.00 (2.64%)
M.Cap ( in Cr)13583.38
Sanofi India (BSE)
peergroup  8252.00 (1.44%)
M.Cap ( in Cr)19090.08
Abbott India (BSE)
peergroup  25827.00 (0.40%)
M.Cap ( in Cr)55141.94
Glaxosmithkline Phar (BSE)
peergroup  2135.00 (3.37%)
M.Cap ( in Cr)35953.04

Shareholding Pattern

PROMOTERS 62.13%
NON-INSTITUTION 35.22%
FI/BANKS/INSURANCE 1.66%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Albert David Ltd.

Albert David Ltd. was incorporated in the year 1938. Its today's share price is 1191.6. Its current market capitalisation stands at Rs 680.01 Cr. In the latest quarter, company has reported Gross Sales of Rs. 3605.89 Cr and Total Income of Rs.3569.61 Cr. The company's management includes Abhishek Seth, Monjori Mitra, Shirish G Belapure, Shourya Sengupta, Anand Vardhan Kothari, Prabhawati Devi Kothari, Umesh Manohar Kunte, Arun Kumar Kothari.

It is listed on the BSE with a BSE Code of 524075 , NSE with an NSE Symbol of ALBERTDAVD and ISIN of INE155C01010. It's Registered office is at D Block, 3rd Floor,Gillander House 8,Netaji Subhas RoadKolkata-700001, West Bengal. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Basu Chanchani & Deb, G Basu & Co, LB Jha & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.